Literature DB >> 21548778

The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.

Kathryn J Moore1, Katey J Rayner, Yajaira Suárez, Carlos Fernández-Hernando.   

Abstract

MicroRNAs (miRNAs) represent an elegant mechanism of posttranscriptional control of gene expression that serves to fine-tune biological processes. These tiny noncoding RNAs (20-22 nucleotide) bind to the 3' untranslated region of mRNAs, thereby repressing gene expression. Recent advances in the understanding of lipid metabolism have revealed that miRNAs, particularly miR-122 and miR-33, play major roles in regulating cholesterol and fatty acid homeostasis. miR-122, the most abundant miRNA in the liver, appears to maintain the hepatic cell phenotype, and its inhibition decreases total serum cholesterol. miR-33, an intronic miRNA located with the sterol response element-binding protein (SREBP)-2 gene, regulates cholesterol efflux, fatty acid β oxidation, and high-density lipoprotein metabolism. These findings have highlighted the complexity of lipid homeostasis and the important role that miRNAs play in these processes, potentially opening new avenues for the treatment of dyslipidemias.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21548778      PMCID: PMC3612434          DOI: 10.1146/annurev-nutr-081810-160756

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  95 in total

Review 1.  Control of protein synthesis and mRNA degradation by microRNAs.

Authors:  Jidong Liu
Journal:  Curr Opin Cell Biol       Date:  2008-03-10       Impact factor: 8.382

2.  Widespread changes in protein synthesis induced by microRNAs.

Authors:  Matthias Selbach; Björn Schwanhäusser; Nadine Thierfelder; Zhuo Fang; Raya Khanin; Nikolaus Rajewsky
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

3.  The regulatory activity of microRNA* species has substantial influence on microRNA and 3' UTR evolution.

Authors:  Katsutomo Okamura; Michael D Phillips; David M Tyler; Hong Duan; Yu-ting Chou; Eric C Lai
Journal:  Nat Struct Mol Biol       Date:  2008-03-30       Impact factor: 15.369

4.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

5.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

6.  Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome.

Authors:  Catherine L Jopling; Sylvia Schütz; Peter Sarnow
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

7.  MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation.

Authors:  Ulf Andersson Ørom; Finn Cilius Nielsen; Anders H Lund
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

Review 8.  Toward microRNA-based therapeutics for heart disease: the sense in antisense.

Authors:  Eva van Rooij; William S Marshall; Eric N Olson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

Review 9.  HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.

Authors:  Alan R Tall; Laurent Yvan-Charvet; Naoki Terasaka; Tamara Pagler; Nan Wang
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

10.  Cell-cycle control of microRNA-mediated translation regulation.

Authors:  Shobha Vasudevan; Yingchun Tong; Joan A Steitz
Journal:  Cell Cycle       Date:  2008-03-25       Impact factor: 4.534

View more
  62 in total

Review 1.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

2.  MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia.

Authors:  Kasey C Vickers; Bassem M Shoucri; Michael G Levin; Han Wu; Daniel S Pearson; David Osei-Hwedieh; Francis S Collins; Alan T Remaley; Praveen Sethupathy
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

3.  Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein.

Authors:  Kasey C Vickers; Kathryn J Moore
Journal:  Circ Res       Date:  2013-11-08       Impact factor: 17.367

4.  MicroRNA associated with dyslipidemia and coronary disease in humans.

Authors:  Elena Flowers; Bradley E Aouizerat
Journal:  Physiol Genomics       Date:  2013-10-29       Impact factor: 3.107

Review 5.  Complexity of microRNA function and the role of isomiRs in lipid homeostasis.

Authors:  Kasey C Vickers; Praveen Sethupathy; Jeanette Baran-Gale; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

6.  Oxidative Stress in HIV Infection and Alcohol Use: Role of Redox Signals in Modulation of Lipid Rafts and ATP-Binding Cassette Transporters.

Authors:  Samikkannu Thangavel; Carmen T Mulet; Venkata S R Atluri; Marisela Agudelo; Rhonda Rosenberg; Jessy G Devieux; Madhavan P N Nair
Journal:  Antioxid Redox Signal       Date:  2018-02-01       Impact factor: 8.401

7.  Inhibition of alpha interferon (IFN-α)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-α.

Authors:  Junli Hao; Wensong Jin; Xinghui Li; Saifeng Wang; Xiaojun Zhang; Hongxia Fan; Changfei Li; Lizhao Chen; Bin Gao; Guangze Liu; Songdong Meng
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

Review 8.  Interplay of mitochondrial metabolism and microRNAs.

Authors:  Julian Geiger; Louise T Dalgaard
Journal:  Cell Mol Life Sci       Date:  2016-08-25       Impact factor: 9.261

9.  Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.

Authors:  Huei-Ru Cheng; Jia-Horng Kao; Hui-Lin Wu; Tai-Chung Tseng; Chen-Hua Liu; Hung-Chih Yang; Tung-Hung Su; Pei-Jer Chen; Ding-Shinn Chen; Chun-Jen Liu
Journal:  Hepatol Int       Date:  2014-11-18       Impact factor: 6.047

10.  Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake.

Authors:  Muhua Yang; Weidong Liu; Christina Pellicane; Christine Sahyoun; Biny K Joseph; Christina Gallo-Ebert; Melissa Donigan; Devanshi Pandya; Caroline Giordano; Adam Bata; Joseph T Nickels
Journal:  J Lipid Res       Date:  2013-12-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.